
Results 1 - 20 of 3,506 in Plavix, Clopidogrel (generic)
Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study
US Taxpayers may be on the hook for the high cost of drug advertising that does little to boost sales, according to a new study led by a University of British Columbia health policy researcher. Comment?
Consumer drug ads drive up health costs: study
When consumer advertising began for the popular blood-thinner Plavix, Medicaid insurance programs for the poor and disabled spent millions more on the drug, even though the ads did not tempt doctors to write more prescriptions, researchers reported on Monday. Comment?
U.S. taxpayers may be on the hook for high-dollar drug advertising that does little to boost sales. Comment?
Did State Medicaid Programs Finance Plavix Direct-to-Consumer Advertising?
w/Photo
When the November 15, 2009, AARP Rx Watchdog Report revealed that manufacturer prices for widely used brand name drugs have climbed dramatically over the last year, despite a negative general inflation rate, many people -- including several Congressmen -- suspected "price gouging" in anticipation of future cost containment under new healthcare ... Comment?
FDA warns that heartburn drugs Prilosec, Nexium block benefits of blood thinner Plavix
w/Photo
Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke. Comment?
Drug ads hike costs but not sales, study says
Drug ads take a lot of heat. Ubiquitous TV commercials aimed at consumers are blamed both for spurring patient demand and boosting health care costs. Comment?
Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial...
From the Departments of Medicine and Pharmacology , Yong Loo Lin School of Medicine, National University Singapore; and the Department of Medicine , National University Hospital, Singapore. Comment?
Direct-to-Consumer Ads Associated With Higher Medicaid Costs
Direct-to-consumer advertising for a commonly prescribed antiplatelet drug does not appear associated with increased use, but may be associated with increased drug costs and Medicaid pharmacy expenditures, according to a report in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Comment?
Consumer drug ads drive up health costs: U.S. study
w/Photo
A new U.S. study suggested that while ads might not directly increase the number of prescriptions, they still affect the cost of publicly funded health care because drugmakers appear to build the cost of the ads into their prices. Comment?
HEALTH CARE REFORM Costs and Consequences of Direct-to-Consumer Advertising for Clopidogrel in Medicaid Michael R. Law, PhD ; Stephen B. Soumerai, ScD ; Alyce S. Adams, PhD ; Sumit R. Majumdar, MD, MPH Arch Intern Med. Comment?
Reconstituted High-Density Lipoprotein Attenuates Platelet Function...
From the Diabetes Complications Laboratory , Metabolic and Vascular Physiology Laboratory , and Lipoproteins and Atherosclerosis Laboratory , Baker IDI Heart and Diabetes Institute, and Australian Centre for Blood Diseases, Monash University , Melbourne, Australia. Comment?
Proton Pump Inhibitors and Clopidogrel. Putting the Interaction in Perspective [Article]
David N. Juurlink MD, PhD* From the Department of Medicine, Sunnybrook Health Sciences Centre; Departments of Medicine, Pediatrics, and Health Policy, Management, and Evaluation, University of Toronto; and the Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. Comment?
Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel...
Niteesh K. Choudhry MD, PhD, Jerry Avorn MD, and Sebastian Schneeweiss MD, ScD From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. Comment?
Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease [Article]
Jeffrey S. Berger MD, MS, Deepak L. Bhatt MD, MPH*, Steven R. Steinhubl MD, Mingyuan Shao MS, P. Gabriel Steg MD, Gilles Montalescot MD, Werner Hacke MD, Keith A. Fox MBChB, A. Michael Lincoff MD, Eric J. Topol MD, Peter B. Berger MD, for the CHARISMA Investigators From New York University School of Medicine , New York, NY; University of ... Comment?
Health Tip: Treating Athlete's Foot
Athlete's foot is a fungal infection, usually causing itching and redness between the toes. Comment?
Health Tip: Bonding With Your New Baby
Caring for a tiny new being can be daunting at first, but new parents should concentrate immediately after birth on creating a strong bond between parent and child. Comment?
Merck KGaA to Expand Research and Development Presence in China
China's research and development organization will become the fourth key R&D hub for Merck Serono division worldwide Merck plans to invest more than 150 million Darmstadt, November 23, 2009 Merck KGaA announced today plans to strengthen its global research and development capabilities of its Merck Serono division by establishing a global R&D center ... Comment?
FDA MedWatch - Meridia (sibutramine): Early Communication about cardiovascular events
ROCKVILLE, Nov. 21, 2009-FDA notified healthcare professionals and patients that it is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events than patients using a placebo . Comment?
Randomized Double-Blind Assessment of the ONSET and OFFSET of the...
Paul A. Gurbel MD*, Kevin P. Bliden BS, Kathleen Butler MD, Udaya S. Tantry PhD, Tania Gesheff BSN, Cheryl Wei PhD, Renli Teng PhD, Mark J. Antonino BS, Shankar B. Patil MD, Arun Karunakaran MD, Dean J. Kereiakes MD, Cordel Parris MD, Drew Purdy MD, Vance Wilson MD, Gary S. Ledley MD, and Robert F. Storey MD From Sinai Center for Thrombosis ... Comment?
Drug ads ineffective for boosting sales, could cost taxpayers: study
US Taxpayers may be on the hook for the high cost of drug advertising that does little to boost sales, according to a new study led by a University of British Columbia health policy researcher. Comment?